Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Limitless X Holdings ( (LIMX) ) just unveiled an announcement.
On May 20, 2025, Limitless X, Inc. amended its Manufacturing and Distributorship License Agreement with LPI to include additional products like NZT-48 Lions Mane and OneShot Nootropic Pre-Workout, effective September 1, 2023. This amendment ensures that future products developed by LPI with the terms ‘NZT’ or ‘OneShot’ will also be covered under the original agreement, solidifying the company’s product offerings and market positioning.
More about Limitless X Holdings
Limitless X Holdings operates in the manufacturing and distribution industry, focusing on products such as NZT-48 Lions Mane, NZT-48 For Her, and OneShot Nootropic Pre-Workout, with a market focus on nootropic supplements.
Average Trading Volume: 3,137
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.49M
For a thorough assessment of LIMX stock, go to TipRanks’ Stock Analysis page.